Gujarat Kidney IPO

Gujarat Kidney IPO

Listed

MainboardOpens 22 December 2025Closes 24 December 2025

Gujarat Kidney and Super Speciality Limited (GKASSL), incorporated in 2019, is a regional healthcare provider in central Gujarat specializing in renal sciences and multi-speciality tertiary care. The company operates 7…

Show more
Live GMPSubscriptionAllotment
Price band
₹108 - ₹114
Issue size
₹250.80 Cr
Lot size
128 shares
Type
Mainboard
GMP
₹2 (+1.8%)
Est. listing
₹116
Est. profit / app
₹256
Retail quota
10.00%

Key ratios

As per RHP / filings
Face value
₹2
EPS
2.74
P/E ratio
41.59
RoNW
36.61%
ROE
36.61%
Debt / Equity
0.15
Advertisement

Timeline

  1. IPO Opens

    22 Dec 2025

  2. IPO Closes

    24 Dec 2025

  3. Allotment

    26 Dec 2025

  4. Listing

    30 Dec 2025

IPO Timeline & Listing Details

EventDate
IPO Open Date22 December 2025
IPO Close Date24 December 2025
Allotment Date26 December 2025
Listing Date30 December 2025

Investment Categories

CategoryLotsAmount
Retail (Min)
1₹14,592
Retail (Max)Just less than ₹2,00,000
13₹1,89,696
SHNI (Min)Just above ₹2,00,000
14₹2,04,288
SHNI (Max)Below ₹10,00,000
68₹9,92,256
BHNIAbove ₹10,00,000
69₹10,06,848

IPO Reservation Details

CategoryReservation
QIB (Qualified Institutional Buyer)75.00%
NII (Non-Institutional Investor)15.00%
SHNI (Small Non-Institutional Investor)5.00%
BHNI (Big Non-Institutional Investor)10.00%
Retail10.00%
Total100.00%

IPO Objectives

  • Proposed acquisition of Parekhs Hospital at Ahmedabad (₹77.00 Cr).
  • Funding capital expenditure for setting up a new hospital in Vadodara (₹30.10 Cr).
  • Part-payment for the already acquired Ashwini Medical Centre (₹12.40 Cr).
  • Acquisition of additional shareholding in the subsidiary Harmony Medicare (₹10.78 Cr).
  • Purchase of robotic equipment (MAKO SmartRobotics™) for the Vadodara facility (₹6.83 Cr).
  • Full or part repayment of certain secured borrowings (₹1.20 Cr).
  • General Corporate Purposes and inorganic growth.

Strengths

  • The company holds a Regional Dominance in Renal Care, established as a leader in central Gujarat for kidney transplants and urology, which ensures a repeat patient base for dialysis services.
  • It utilizes a Successful Acquisition Model, with a proven track record of acquiring smaller hospitals and turning them profitable quickly to accelerate growth.
  • The business exhibits High Capital Efficiency through an asset-light model (leased premises), resulting in a high RoCE of 37.65% and a strong PAT margin of 23.61% in FY25.
  • It is making a Metropolitan Entry into the Ahmedabad market through the strategic acquisition of Parekhs Hospital, funded by IPO proceeds.
  • The company maintains a Technological Edge by investing in advanced robotics and medical equipment to improve surgical outcomes and attract specialized medical talent.

Weaknesses

  • There is significant Geographical Concentration, with 100% of operations currently in Gujarat, making the company vulnerable to regional policy or economic changes.
  • The Aggressive Valuation with a Post-IPO P/E of 41.59x is high compared to historical levels and depends on sustaining the exceptional growth rates seen in FY25.
  • The business faces Integration Risk, as it relies on successfully merging medical staff and hospital cultures after acquisitions, which could cause operational strain.
  • The Low Retail Quota (10%) may lead to extreme oversubscription, significantly reducing the allotment chances for individual retail investors.
  • There is a Liquidity and Debt risk, as the company is reliant on IPO proceeds to settle ₹12.40 Cr in outstanding payments for prior hospital acquisitions.
Advertisement

Financial Performance

Period Ended30 Jun 202531 Mar 202531 Mar 202431 Mar 2023
Assets (₹ Cr.)61.5955.3420.533.87
Revenue (₹ Cr.)15.2740.45.480
PAT (₹ Cr.)5.49.51.71-0.01
Net Worth (₹ Cr.)30.5625.7110.80.37

Peer Comparison

CompanyP/B RatioP/E RatioRONW (%)Net Worth (₹ Cr.)
Gujarat Kidney & Super Speciality22.6241.5936.61%30.56
Yatharth Hospital & Trauma Care3.8642.699.03%1,637
Gpt Healthcare Limited4.4225.8617.11%248

Subscription Details

Daily Bids Status

CategoryDay 1Day 2Day 3
QIB0.34x0.34x1.06x
NII1.98x2.97x5.73x
S-HNI0.98x2.54x6.68x
B-HNI2.48x3.18x5.25x
RII5.07x10.7x19.04x
Total1.54x2.72x5.21x

Overall Subscription Statistics

CategoryShares OfferedShares BidBid Amount (₹ Cr)
QIB77,26,88081,88,92893.35
NII33,00,0001,88,99,840215.46
Small NII11,00,00073,46,94483.76
Big NII22,00,0001,15,52,896131.7
RII22,00,0004,18,79,808477.43
Total1,32,26,8806,89,68,576786.24
Advertisement

Company Details

  • Gujarat Kidney & Super Speciality Ltd.
  • Plot No. 1, City Sarve No. 1537/A, Jetalpur Road, Gokak Mill Compound, Alkapuri, Vadodara, Gujarat-390020
  • +91 265 298 4800
  • info@gujaratsuperspecialityhospital.com
  • http://www.gujaratsuperspecialityhospital.com/

Registrar Details

Frequently Asked Questions

What is the primary speciality of Gujarat Kidney & Super Speciality?
The company specializes in renal sciences, including kidney transplants, dialysis, and advanced urology, alongside other super-speciality services like orthopaedics and robotic surgery.
When does the Gujarat Kidney IPO open and close?
The IPO opens for subscription on Monday, December 22, 2025, and closes on Wednesday, December 24, 2025.
What is the IPO price band and minimum retail investment?
The price band is fixed at ₹108 to ₹114 per share. A retail investor can apply for a minimum lot of 128 shares, requiring an investment of ₹14,592.
What is the current GMP of Gujarat Kidney IPO today?
As of December 21, 2024, the GMP is approximately ₹7, indicating a potential listing price of ₹121 (a 6.14% premium over the issue price).
How will the IPO proceeds be used for growth?
The company will use the fresh issue proceeds primarily to acquire Parekhs Hospital in Ahmedabad (₹77 Cr), set up a new hospital in Vadodara, and purchase advanced robotic surgery equipment.
Where will the Gujarat Kidney shares be listed?
The shares are proposed to list on the mainboard of both the BSE and NSE, with a tentative listing date of December 30, 2025.

Gujarat Kidney IPO News & Updates

Follow the latest updates for Gujarat Kidney IPO, including grey market moves and allotment news.

Gujarat Kidney IPO IPO Pages

Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.

Gujarat Kidney IPO Details

Issue size, price, financials, and company info

Gujarat Kidney IPO GMP

Live grey market premium and listing estimate

Gujarat Kidney IPO Subscription

QIB, NII, Retail, SHNI and BHNI subscription

Gujarat Kidney IPO Allotment

Allotment date, chances, and check by PAN

Gujarat Kidney IPO Review

SWOT, strengths, risks, and IPO review

Gujarat Kidney IPO FAQ

Common questions on dates, GMP, and allotment

Gujarat Kidney IPO Registrar

Registrar website and how to check allotment

Gujarat Kidney IPO Timeline

Open, close, allotment, and listing dates

Gujarat Kidney IPO News

Updates, blogs, and latest IPO news

Sources

We match Gujarat Kidney IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.

  • SEBIRules for IPO allotment and disclosures in India
  • NSEExchange notices, bidding data, and listing updates
  • BSEExchange notices and IPO allotment check tools
  • RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
  • MUFG Intime India Pvt.Ltd.Official site to check allotment status for this IPO

Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.

Reviewed by

Dinesh Agrawal · Lead IPO Analyst

15+ years in Indian markets and IPO research. He reviews IPO dates and key details before they go live.

Loading comments...